Synthesis and pharmacological studies of 3-amino-2-methyl-1-phenylpropanones as hypolipidemic agents in rodents

Archiv der Pharmazie

Volumn 329, Issue 7, 1996, Pages 329-338

  Huang, Yunsheng ^a   Hall, Iris H ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

3 amino 2 methyl 1 phenylpropanones; cholesterol levels; hypolipidemics; triglyceride levels

Indexed keywords

2 METHYL 3 (4 PYRROLIDINOCARBONYLMETHYLPIPERAZIN 1 YL) 1 PHENYLPROPANONE; 2 METHYL 3 (PERHYDROAZEPIN 1 YL) 1 PHENYLPROPANONE; 3 (4 METHYLPIPERAZIN 1 YL) 1 PHENYLPROPANONE; ANTILIPEMIC AGENT; CHOLESTEROL; CLOFIBRATE; GEMFIBROZIL; MEVINOLIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; DRUG SYNTHESIS; ENZYME ACTIVITY; HYPERLIPIDEMIA; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANTILIPEMIC AGENTS; AORTA; CHOLESTEROL; ENZYME INHIBITORS; HYPERLIPIDEMIAS; INTESTINAL MUCOSA; KETONES; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; RATS; RATS, SPRAGUE-DAWLEY; SPECTROPHOTOMETRY, INFRARED; STRUCTURE-ACTIVITY RELATIONSHIP; TRIGLYCERIDES;

EID: 0030017909     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/ardp.19963290702     Document Type: Article

References (24)

1. Y. Huang, I.H. Hall, Eur. J. Med.Chem. 1996, 31, 281-290.
2. F.F.Blicke, J.H. Burckhalter, J. Am. Chem. Soc. 1942, 64, 451-454.
3. A.T. Ness, J.V. Pastewka, A.C. Peacock, Clin. Chim. Acta 1964, 10, 229-237.
4. T.C. Huang, CP Chen, V. Wefler, A. Raftery, Anal. Chem. 1961, 33, 1405-1407.
5. M.W. McGowan, J.D. Artiss, D.R. Strandbergh, B. Zak, Clin. Chem. 1983, 29, 538-542.
6. J. Folch, M. Lees, G.h.L. Stanley, J. Biol. Chem. 1957, 226, 497-509.
7. E.G.Bligh, W.R. Dyer, Can. J. Biochem. Physiol.1958, 37, 911-917.
8. J.H. Bragdon, J. Biol. Chem. 1951, 190, 513-517.
9. C.P.Stewart, E.G. Hendry, Biochem. J. 1935, 29, 1683-1689.
10. O.H. Lowry, W.J. Rosebrough, A.L. Farr, R.J. Randall, J. Biol. Chem. 1951, 193, 265-275.
11. F.T. Hatch, R.S. Lees, Adv. Lipid Res. 1968, 6, 1-68.
12. R.J. Havel, A.A. Eder, J.H. Bragdon, J. Clin. Invest. 1955, 34, 1345-1353.
13. S. Mookerjea, C.E. Parks, A. Kulsis, Lipids 1975, 10, 374-382.
14. I.H. Hall, O.T. Wong, S.D. Wyrick, Pharm. Res. 1988, 5, 413-420.
15. A.G. Goodridge, J. Biol. Chem.1973, 248, 4318-4326.
16. G. Hoffman, L. Weiss, O. Weiland, Anal. Biochem. 1978, 84, 441-448.
17. S. Shefer, S. Hauser, E.M. Mosbach, J. Lipid Res. 1968, 9, 328-333.
18. S. Balasubramaniam, K.A. Mitropoulos, S. Venkatesan, Eur. J. Biochem. 1978, 90, 377-383.
19. G.T. Haven, J.R. Kizemein, T.T. Nguyen, Res. Comm. Chem. Path. Pharmacol. 1973, 6, 253-262.
20. F. Wada, K. Hirata, Y. Sakamoto, J. Biochem. (Tokyo) 1969, 65, 171-175.
21. M.D. Greenspan, J.W. Lowenstein, J. Biol. Chem. 1968, 243, 6273-6280.
22. R.G. Lamb, S.D. Wyrick, C. Pianladosi, Atherosclerosis 1977, 27, 147-154.
23. R.D. Mavis, J.N. Finkelstein, B.P. Hall, J. Lipid Res. 1978, 19, 467-477.
24. A. Chait, P.H. Iverius, J.D. Brunzel, J. Clin. Invest. 1982, 69, 460-493.